---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-055841"
form_type: "8-K"
ticker: null
cik: "0001811623"
company_name: "PaxMedica, Inc."
filed_at: "2024-05-01T23:59:59+00:00"
generated_at: "2026-06-03T03:11:12.732209+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Nasdaq to delist PaxMedica common stock on May 2, 2024 due to minimum bid price noncompliance

## Summary
- Nasdaq Panel determined to delist PaxMedica common stock; trading suspended at open on May 2, 2024.
- Reason: violation of Nasdaq minimum bid price requirement (Listing Rule 5550(a)(2)).
- Company expects common stock to be eligible for quotation on OTC Pink Market under symbol PXMD.
- Company has 15 days to request review by the Nasdaq Listing and Hearing Review Council.

## SEC filing metadata
- accession: 0001104659-24-055841
- form_type: 8-K
- cik: 0001811623
- company_name: PaxMedica, Inc.
- filed_at: 2024-05-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811623/000110465924055841/0001104659-24-055841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811623/000110465924055841/tm2413263d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-055841
- JSON: https://secwatch.observer/filing/0001104659-24-055841.json
- Plain text: https://secwatch.observer/filing/0001104659-24-055841.txt

## Key facts
- Listing & Compliance Notices
  PaxMedica, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 30, 2024, The Nasdaq Stock Market LLC (“Nasdaq”) notified PaxMedica, Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock and that trading of the Company’s securities will be suspended at the open of trading on May 2, 2024. The Company expects its common stock will be eligible for quotation on the OTC Pink Market under its existing symbol, “PXMD.” The Panel reached its decision because the Company is in violation of the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). The Company has 15 days after the date i
  evidence_url: https://www.sec.gov/Archives/edgar/data/1811623/000110465924055841/0001104659-24-055841-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.